Stay updated with breaking news from Mark Oki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ranked 94th Fastest Growing Company in North AmericaRanked 21st Fastest Growing Life Sciences CompanyENGLEWOOD, CO / ACCESSWIRE / November 17, 2022 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU)
ENGLEWOOD, CO / ACCESSWIRE / November 7, 2022 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription
Following a corporate review, Aytu BioPharma is indefinitely suspending clinical development and removing expenses related to AR101/enzastaurin, Healight, and NT0502, and focusing on revenue growth and
Adzenys XR-ODT is FDA-Approved as Bioequivalent to Adderall XRReported Supply Disruptions of Adderall XR Generic Equivalents Have the Potential to Affect Patient Access to ADHD MedicationsENGLEWOOD, CO
27.09.2022 - Record fourth quarter and fiscal year net revenue driven by strong growth in Prescription segmentPositive Adjusted EBITDA within Prescription segmentCompany to Host Conference Call Today at 4:30pm ETENGLEWOOD, CO / ACCESSWIRE / September 27, 2022 / ...